Skip to main content
NEPHROPLUS · Health Care · 2026-08-07

Nephrocare Health Services Ltd

MARKET: BULL TOPPING · 2026-08-07
₹694.2
+0.36% today
₹6,980 Cr · Mid cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.

Visit company website →
P/E (TTM)
75.0
Forward 29.9
Earnings Growth (YoY)
+0.3%
Revenue +21.2%
ROE
+9.0%
Profit margin +7.7%
vs 52W High
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 33
1w13w26w
Week 33 — mature, watch for distribution
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.28x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
MA20 gently rising · +2.5% vs MA50 +5.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↑ Building
Stage 2%
59.3%
20d Δ
+7.4pp
1M return
+1.2%
3M return
+9.0%
Industry Stage-2 % · last 20 days
Industry has 16 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2025-12-17 → 2026-08-07
S? 33w
2025-12-172026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 33w current
Total tracked: 33 weeks across 1 stage run.
1M
+9.6%
3M
+27.4%
6M
+33.6%
YTD
+49.7%
1Y
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-08-07S
Wk 33 · Vol x
2026-08-06S
Wk 32 · Vol x
2026-08-05S
Wk 32 · Vol x
2026-08-04S
Wk 32 · Vol x
2026-08-03S
Wk 32 · Vol x
2026-07-31S
Wk 32 · Vol x
2026-07-30S
Wk 31 · Vol x
2026-07-29S
Wk 31 · Vol x
2026-07-28S
Wk 31 · Vol x
2026-07-27S
Wk 31 · Vol x
2026-07-24S
Wk 31 · Vol x
2026-07-23S
Wk 30 · Vol x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹678.5
200 DMA
52W High
52W Low
5D Low
₹688.8
Resistance levels (recent highs)
20d High
₹713.2
60d High
₹751.3
120d High
₹751.3
250d High
Next resistance
+2.7%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.